Protective effect of scFv-DAF fusion protein on the complement attack to acetylcholine receptor: a possible option for treatment of myasthenia gravis

Authors

Chen Song, Fourth Military Medical University, Xi'an, China
Zhikai Xu, Fourth Military Medical University, Xi'an, China
Jianting Miao, Fourth Military Medical University, Xi'an, China
Jiang Xu, Fourth Military Medical University, Xi'an, China
Xingan Wu, Fourth Military Medical University, Xi'an, China
Fanglin Zhu, Fourth Military Medical University, Xi'an, China
Hong Lin, Fourth Military Medical University, Xi'an, China
Zhuyi Li, Fourth Military Medical University, Xi'an, China
Henry J. Kaminski, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

5-2012

Journal

Muscle and Nerve

Volume

Volume 45, Issue 5

Inclusive Pages

668-675

Keywords

Antigens; CD55--pharmacology; Complement System Proteins--pharmacology; Receptors; Cholinergic--metabolism; Recombinant Fusion Proteins--pharmacology

APA Citation

Song, C., Xu, Z., Miao, J., Xu, J., Wu, X., Zhang, F., Lin, H., Li, Z., Kaminski, H. J. (2012). Protective effect of scFv-DAF fusion protein on the complement attack to acetylcholine receptor: A possible option for treatment of myasthenia gravis. Muscle and Nerve, 45(5), 668-675.

Peer Reviewed

1